Abstract
Interferon production in hepatitis B virus carriers with normal liver functions was preserved, whereas in carriers with chronic hepatitis it was depressed. The lower interferon production in hepatitis B virus carriers with chronic hepatitis appears to be the result rather than the cause of chronic hepatic disease.
Full text
PDF![923](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f0/273294/abee81a4c098/jcm00185-0181.png)
![924](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f0/273294/38ab4cf8f2ae/jcm00185-0182.png)
![925](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61f0/273294/521cbfff102b/jcm00185-0183.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Desmyter J. The use of interferon in viral hepatitis B. Tex Rep Biol Med. 1977;35:516–522. [PubMed] [Google Scholar]
- Greenberg H. B., Pollard R. B., Lutwick L. I., Gregory P. B., Robinson W. S., Merigan T. C. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med. 1976 Sep 2;295(10):517–522. doi: 10.1056/NEJM197609022951001. [DOI] [PubMed] [Google Scholar]
- Kaplan P. M., Greenman R. L., Gerin J. L., Purcell R. H., Robinson W. S. DNA polymerase associated with human hepatitis B antigen. J Virol. 1973 Nov;12(5):995–1005. doi: 10.1128/jvi.12.5.995-1005.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakao M., Mizoguchi Y., Monna T., Yamamoto S., Morisawa S. Studies on an inhibitory factor to phytohemagglutinin-induced lymphocyte transformation found in the serum of patients with various liver diseases. Acta Hepatogastroenterol (Stuttg) 1978 Oct;25(5):335–343. [PubMed] [Google Scholar]
- Tolentino P., Dianzani F., Zucca M., Giacchino R. Decreased interferon response by lymphocytes from children with chronic hepatitis. J Infect Dis. 1975 Oct;132(4):459–461. doi: 10.1093/infdis/132.4.459. [DOI] [PubMed] [Google Scholar]
- Virelizier J. L., Gresser I. Role of interferon in the pathogenesis of viral diseases of mice as demonstrated by the use of anti-interferon serum. V. Protective role in mouse hepatitis virus type 3 infection of susceptible and resistant strains of mice. J Immunol. 1978 May;120(5):1616–1619. [PubMed] [Google Scholar]